Named on one round in the feed.
Since 2023-02-28
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Oricell Oricell develops cell therapies specifically aimed at treating cancer patients, particularly through advanced CAR-T technology. | Series B Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $45M | 2023-02-28 | [ PART ] |